Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Harnessing phagocytes for amyloid clearance: Development of a novel bispecific phagocyte engager (LC Fibril x CD64) for AL amyloidosis

Jing Fu, Huihui Ma, Gavreel Kalantarov, Michael Hughes, Guifen Liu, Markus Mapara, Suzanne Lentzsch

Blood (2025) 146 (Supplement 1): 3919.

https://doi.org/10.1182/blood-2025-3919

Published: 2025

Journal Articles

Effect of isatuximab use in combination with autologous stem cell transplant on mobilized stem cell product and post-transplant immune recovery - Results of a randomized prospective Phase 2 trial

Divaya Bhutani, Shami Chakrabarti, Rajshekhar Chakraborty, Michael Hughes, Suzanne Lentzsch, Markus Mapara, Abhinav Deol, Joseph Uberti, Ran Reshef

Blood (2025) 146 (Supplement 1): 4062.

https://doi.org/10.1182/blood-2025-4062

Published: 2025

Journal Articles

Deciphering the IKZF1 and MAP4K2 protein interactome in RASMut multiple myeloma reveals a novel regulatory pathway of IKZF1

Josefine Krüger, Shirong Li, Guifen Liu, Yuen Lam Dora Ng, Michael Hughes, Rajshekhar Chakraborty, Divaya Bhutani, Jan Krönke, Suzanne Lentzsch, Jing Fu

Blood (2025) 146 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2025-2150

Published: 2025

Journal Articles

Long-term follow-up of venetoclax therapy in AL amyloidosis

Divaya Bhutani, Rajshekhar Chakraborty, Suzanne Lentzsch, Michael Hughes, Michaela Liedtke, Jeffrey Zonder, Mansen Yu, Anita D'Souza

Blood (2025) 146 (Supplement 1): 7497.

https://doi.org/10.1182/blood-2025-7497

Published: 2025

Journal Articles

Outcomes of patients with mayo stage IIIb systemic AL amyloidosis treated with daratumumab-based frontline therapy

Simon Zhen, Divaya Bhutani, Mathew Maurer, Karan Wats, Yevgeniy Brailovsky, Michael Hughes, Jai Radhakrishnan, Markus Mapara, Suzanne Lentzsch, Rajshekhar Chakraborty

Blood (2025) 146 (Supplement 1): 5740.

https://doi.org/10.1182/blood-2025-5740

Published: 2025

Journal Articles

Machine learning uncovers prognostically distinct myeloma cast nephropathy phenotypes not captured by standard risk stratification systems

Michael Hughes, Yiran Peng, Shikun Wang, Andrew Laine, Jai Radhakrishnan, Metodi Balev, Divaya Bhutani, Markus Mapara, Andrew Eisenberger, Suzanne Lentzsch, Rajshekhar Chakraborty

Blood (2025) 146 (Supplement 1): 5756.

https://doi.org/10.1182/blood-2025-5756

Published: 2025

Journal Articles

Determinants of renal survival in patients treated for monoclonal gammopathy of renal significance

Samuel Rubinstein, Yusha Liu, Rajshekhar Chakraborty, Michael Hughes, Suzanne Lentzsch, Jing Christine Ye, Divaya Bhutani

Blood (2025) 146 (Supplement 1): 3973.

https://doi.org/10.1182/blood-2025-3973

Published: 2025

Journal Articles

Isatuximab for the treatment of monoclonal gammopathy of renal significance (MGRS): Results from a prospective multicenter Phase 2 trial

Divaya Bhutani, Rajshekhar Chakraborty, Michael Hughes, Suzanne Lentzsch, Samuel Pan, Shayan Shirazayan, Sherley Mejia, Naomi Sender, Elizabeth Shelton, Meghan Sise

Blood (2025) 146 (Supplement 1): 579.

https://doi.org/10.1182/blood-2025-579

Published: 2025

Journal Articles

Development of a high-affinity antibody specific to the predominant λ light chain amyloid subtype for AL amyloidosis immunotherapy

Michael Hughes, Gavreel Kalantarov, Jing Fu, Miroslav Sekulic, Glen Markowitz, Josefine Krüger, Guifen Liu, HuiHui Ma, Markus Mapara, Suzanne Lentzsch

Blood (2025) 146 (Supplement 1): 576.

https://doi.org/10.1182/blood-2025-576

Published: 2025

Journal Articles

Better renal response with daratumumab in patients with monoclonal immunoglobulin deposition disease

Divaya Bhutani, Samuel Rubinstein, Rajshekhar Chakraborty, Michael Hughes, Suzanne Lentzsch, Lu Dai, Micah Richardson, J Christine Ye

Blood (2025) 146 (Supplement 1): 2194.

https://doi.org/10.1182/blood-2025-2194

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Harnessing phagocytes for amyloid clearance: Development of a novel bispecific phagocyte engager (LC Fibril x CD64) for AL amyloidosis

Effect of isatuximab use in combination with autologous stem cell transplant on mobilized stem cell product and post-transplant immune recovery - Results of a randomized prospective Phase 2 trial

Deciphering the IKZF1 and MAP4K2 protein interactome in RASMut multiple myeloma reveals a novel regulatory pathway of IKZF1

Long-term follow-up of venetoclax therapy in AL amyloidosis

Outcomes of patients with mayo stage IIIb systemic AL amyloidosis treated with daratumumab-based frontline therapy

Machine learning uncovers prognostically distinct myeloma cast nephropathy phenotypes not captured by standard risk stratification systems

Determinants of renal survival in patients treated for monoclonal gammopathy of renal significance

Isatuximab for the treatment of monoclonal gammopathy of renal significance (MGRS): Results from a prospective multicenter Phase 2 trial

Development of a high-affinity antibody specific to the predominant λ light chain amyloid subtype for AL amyloidosis immunotherapy

Better renal response with daratumumab in patients with monoclonal immunoglobulin deposition disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only